Pleural Mesothelioma

Overview

Symptoms

  • Persistent cough or wheezing

  • Fatigue and general weakness

  • Unexpected weight loss and loss of appetite

  • Fever or night sweats

  • Difficulty swallowing

Diagnosis

  • Chest PET Scan – Helps assess spread and distinguish cancerous from benign tissue.

  • Chest MRI – Sometimes used to evaluate invasion into the chest wall or diaphragm.

  • Pleuroscopy/Medical Thoracoscopy – A less invasive cousin of VATS, often done under sedation and local anesthesia that allows for direct visualization and good-sized biopsies

  • Thoracotomy – The most invasive procedure that is used less often today and reserved for cases where thoracoscopy isn’t feasible/adequate or when more extensive surgical assessment is needed.

Staging

  • M – Metastasis: whether cancer has spread to distant parts of the body

  • T3 – Psum above approximately 30 millimeters (with locally advanced, but still potentially resectable features)

  • T4 – The most advanced local invasion, defined by what the tumor invades rather than thickness and carries a distinctly worse prognosis regardless of thickness

  • N2 – Cancer has spread to the lymph nodes on the opposite side (contralateral) of the chest or to nodes above the collarbone

  • Stage IIIA – T1, N2; T2 N1 or N2; any T3

  • Stage IIIB – any T4 (any N)

  • Stage IV – any M1 (any T or N)

Treatments

Chemotherapy/Immunotherapy

  • Carboplatin (Paraplatin) or Cisplatin (Platinol) Plus Gemcitabine (Gemzar) – Sometimes offered when a patient can’t take Pemetrexed due to contraindications, intolerance or cost considerations.

  • Vinorelbine (Navelbine) – Typically offered second-line once a patient progresses on platinum doublet chemotherapy, but may be offered first-line to pleural mesothelioma patients who can’t tolerate or aren’t good candidates for platinum doublet chemotherapy or immunotherapy.

  • Pemetrexed (Alimta) – Sometimes offered second-line as maintenance monotherapy to continue disease control or first-line for selected elderly patients or those unfit for platinum doublet chemotherapy and immunotherapy.

  • Hyperthermic Intrathoracic Chemotherapy (HITHOC) – Always done in conjunction with surgery, HITHOC delivers heated chemotherapy (typically Cisplatin-based) directly into the pleural cavity to kill microscopic disease left behind after surgery.

  • Pressurized Intrathoracic Aerosol Chemotherapy (PITAC) – An early-stage, experimental procedure that is not combined with surgical removal of the main tumor. PITAC delivers chemotherapy as a pressurized aerosol mist into the pleural cavity via a special device, which spreads it evenly across the chest surfaces and helps it penetrate tumor tissue.

Surgery

Radiation Therapy

Clinical Trials

A note about this information

phone icon CALL FOR HELP NOW 888.891.2200